The nation of Zimbabwe has rejected a major US healthcare agreement worth $367m (£272m) over five years over the United States' demand for sensitive biological samples.
This rejection was revealed after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the deal was "unbalanced".
An official spokesman has since explained that the United States was seeking health data for scientific study and commercial gain but refused to guarantee the resulting advantages from future treatments.
"We must now begin the difficult and regrettable task of winding down our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the US had provided more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to reach a agreement suitable to both sides so the nation's vital HIV treatment initiative can be sustained.
Wider Background
Zimbabwe's decision comes after a similar case in neighbouring Kenya, where a court suspended a similar health funding agreement after legal challenges were raised about the safety of Kenyans' health data.
After returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed assistance for the US government, but Trump stated its expenditure was "inefficient" and his administration was seeking direct bilateral deals to boost transparency and responsibility.
As per statements, 16 nations in Africa have so far signed similar agreements, constituting over $18.3bn of fresh investment.
Details of the Rejected Deal
The money for Zimbabwe would have supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We are confident this partnership could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy through US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana argued the proposed deal was "asymmetrical".
"Our nation was requested to surrender its genetic material and health information indefinitely, with no equivalent promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that provided information," his statement read.
"In essence, our country would supply the basic resources for medical research without any certainty that the end products would be available to our population should a new pandemic emerge."
National Interest and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending systems previously established via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to manage potential global health emergencies.
"This framework is intended to ensure that when a country contributes its samples, the resulting advantages – including medicines and cures – are distributed fairly, not monopolised exclusively by those with the capability to create them."
These objections regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing discussions with our American counterparts on how subsequent collaboration might be designed in a manner that honours the independence and interests of both nations."
Health Experts Response
A leading public health body stated it recognised the government's concerns, but urged that negotiations should continue since much of the country's Aids initiatives depended on international support.
"In cases where technical issues exist, such as those involving data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," the group added.
The halted deal emphasises the complex debate between receiving vital international aid and safeguarding local interests in an increasingly interconnected world.